Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
07 Giugno 2024 - 11:00PM
NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”),
announced today that its shareholders voted in favour of all items
of business brought before them at the Company’s annual and special
meeting of shareholders held on June 7, 2024.
At the meeting, the six nominees to the
Company’s Board of Directors, Chris Dobbin, Wayne Myles, Michael
O’Keefe, Dana Hatfield, Marie Mullally and Anne Whelan, were
elected for the ensuing year. Grant Thornton LLP was re-appointed
as the Company’s auditor to hold office until the next annual
meeting of shareholders or until its successor is duly appointed,
at a remuneration to be fixed by the Board.
In addition, the third amended and restated
equity incentive plan of the Company (the “Plan”), which amends and
restates the Company’s second amended and restated equity incentive
plan, was approved and ratified. The Plan is a 10% “rolling” plan
and includes housekeeping amendments and other amendments required
by the TSX Venture Exchange in order to comply with its updated
policies. More information on the Plan, including a copy of the
Plan, is available in the Company’s Management Information Circular
dated May 7, 2024 filed on SEDAR+.
The proxy results for the annual and special
meeting of the shareholders held on June 7, 2024 were as
follows:
TOTAL SHAREHOLDERS
VOTED BY
PROXY: |
40 |
TOTAL SHARES ISSUED
& OUTSTANDING: |
86,209,252 |
TOTAL SHARES
VOTED: |
40,731,701 |
TOTAL % OF SHARES
VOTED: |
47.25% |
About Nova Leap
Nova Leap is an acquisitive home health care
services company operating in one of the fastest-growing industries
in the U.S. & Canada. The Company performs a vital role within
the continuum of care with an individual and family centered focus,
particularly those requiring dementia care. Nova Leap achieved the
#42 ranking on the 2021 Report on Business ranking of Canada’s Top
Growing Companies, the #2 ranking on the 2020 Report on Business
ranking of Canada’s Top Growing Companies and the #10 Ranking in
the 2019 TSX Venture 50™ in the Clean Technology & Life
Sciences sector. The Company is geographically diversified with
operations in 10 different U.S. states within the New England,
Southeastern, South Central and Midwest regions as well as in Nova
Scotia, Canada.
CAUTIONARY STATEMENT:
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/49bf6f7e-b0b3-4daa-9512-d0c8696b5bdb
For further information:
Chris Dobbin, CPA, ICD.D
Director, President and CEO
T: 902 401 9480
E:cdobbin@novaleaphealth.com
Grafico Azioni Nova Leap Health (TSXV:NLH)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Nova Leap Health (TSXV:NLH)
Storico
Da Dic 2023 a Dic 2024